.png?width=150&name=MMS%20logo_without%20Tagline%20(Full%20Color).png "MMS logo_without Tagline (Full Color)")
Challenges of Rare Disease Drug Development Programs
By: Amanda Beaster, Ph.D.
Tips for Successful Medical Device Development and Approval
By: Gary Pekoe, Senior Medical Writer
How to Train Users on the Clinical Trial Information System (CTIS) Ahead of New Regulations
By: Kasim McLain, Manager of Transparency
Data CRO Expands its Virtual Learning Portfolio
CANTON, Mich. (July 28, 2021) – MMS Holdings (MMS) – an award-winning, data-focused CRO – announced that its ...
How to Maximize FSP Partnerships – Scalability, Innovation, and Efficiencies
by Donnelle LaDouceur, Director of Functional Service Solutions
Attention Sponsors, Be Prepared to Publish Interim Clinical Study Results
By Karim Ibazatene, Associate Director of Clinical Trials Transparency Right ...
Whitepaper: CMC Regulatory Considerations for Successful Submission Planning
Combination products have emerged as powerful technologies for delivering novel molecules and modernizing ...
Health Data Research UK Selects MMS as Data Services Partner for the International COVID-19 Data Alliance
LONDON (July 15, 2021) – MMS Holdings Inc. (MMS) – an award-winning, data-focused CRO – announced today that ...